Diabetic Macular Edema (DME) Recruiting Phase 2 Trials for Ranibizumab (DB01270)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03927690Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular EdemaTreatment
NCT03161652Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular EdemaTreatment